Apple’s Platform Control Faces Legal Test in Epic Games Remedy Phase
Note: Featured image is for illustrative purposes only and does not represent any specific product, service, or entity mentioned in…
Note: Featured image is for illustrative purposes only and does not represent any specific product, service, or entity mentioned in…
Note: Featured image is for illustrative purposes only and does not represent any specific product, service, or entity mentioned in…
Note: Featured image is for illustrative purposes only and does not represent any specific product, service, or entity mentioned in…
Note: Featured image is for illustrative purposes only and does not represent any specific product, service, or entity mentioned in…
Note: Featured image is for illustrative purposes only and does not represent any specific product, service, or entity mentioned in…
Enterprise Upgrades Offset Consumer Caution in PC Market Rebound Global PC shipments have surged unexpectedly in the third quarter, with…
A scientist has developed a novel deep learning framework that tackles one of the most persistent challenges in AI-powered drug discovery. The approach focuses specifically on improving how models generalize to new protein families and chemical structures they haven’t encountered during training.
Researchers are reporting a potential breakthrough in applying machine learning to the earliest stages of drug discovery, addressing a critical limitation that has hampered real-world implementation. According to sources familiar with the research, a new framework specifically targets the “generalizability gap” that causes AI models to fail unpredictably when encountering unfamiliar chemical structures.
DuPont has reportedly received a short-term catalyst buy rating from Deutsche Bank analysts ahead of its November electronics division spinoff. According to investment club sources, the plan is to hold both DuPont and the new Qnity Electronics shares due to significant valuation discounts compared to industry peers.
Chemical giant DuPont has been named a short-term catalyst buy idea by Deutsche Bank analysts, according to recent reports from the CNBC Investing Club. The positive rating comes ahead of the company’s planned November 1 spinoff of its electronics division, which will operate as a separate entity called Qnity Electronics.
Breaking the Mold: Meta’s Counter-Intuitive Hiring Strategy While much of Silicon Valley appears to be graying, Meta is making a…